Warrington and Halton<\/p><\/td> | 11,562<\/p><\/td> | 15,957<\/p><\/td><\/tr><\/tbody><\/table> <\/p> In addition to payments made for medical staff, the figures in the above table include the costs of temporary and agency workers engaged in other activities, such as employees contracted for provision of other administration and support services.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"}
}
, "answeringMemberConstituency" : {"_value" : "Ludlow"}
, "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"}
, "dateOfAnswer" : {"_value" : "2016-10-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-10-19T15:53:29.733Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-10-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: Agency Workers"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much (a) Royal Liverpool and Broadgreen University Hospital NHS Trust, (b) St Helens and Knowsley Hospital Services NHS Trust, (c) Aintree University Hospitals NHS Foundation Trust, (d) Wirral University Teaching Hospital NHS Foundation Trust, (e) Southport and Ormskirk NHS Trust and (f) Warrington and Halton Hospitals NHS Foundation Trust spent on agency medical staff in (i) 2014-15 and (ii) 2015-16.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"}
}
, "tablingMemberConstituency" : {"_value" : "Knowsley"}
, "tablingMemberPrinted" : [{"_value" : "Mr George Howarth"}
], "uin" : "48122"}
, {"_about" : "http://data.parliament.uk/resources/599471", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/599471/answer", "answerText" : {"_value" : " Improving early diagnosis of cancer is a priority for this Government, and was clearly highlighted in the report Achieving World-Class Cancer Outcomes published last year by the Independent Cancer Taskforce. Earlier diagnosis makes it more likely that patients, including children with cancer, will receive effective treatments. We have committed to implementing all the recommendations of the Taskforce including that, by 2020, everyone referred with a suspicion of cancer will receive either a definitive diagnosis or the all-clear within four weeks (28 days).<\/p> NHS England has the funds necessary to improve cancer services over the next five years, including up to £300 million by 2020 to support earlier diagnosis of cancer and the £10 billion of real terms increase in National Health Service funding by 2020-21. The recommendations in the Taskforce report give direction as to where these funds should be targeted.<\/p> In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline \u2018Suspected cancer: recognition and referral\u2019 includes new recommendations for childhood cancers.<\/p> NICE also addressed generally, non-site specific symptoms of concern in children and young people, recommending that GPs should take into account the insight and knowledge of parents and carers when considering making a referral for suspected cancer. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2016-10-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-10-19T14:41:21.11Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-10-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to improve early diagnosis of childhood cancers; and if he will make available additional funding to improve such early diagnosis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "48110"}
, {"_about" : "http://data.parliament.uk/resources/599473", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/599473/answer", "answerText" : {"_value" : " NHS England has advised that the Chemotherapy Clinical Reference Group (CRG) discussed the use of bisphosphonates for the indication of preventing secondary breast cancer during a meeting held in September 2015. It was raised in the context of guidance being developed by the Breast Cancer Clinical Reference Group and whether, through the Chemotherapy CRG, NHS England could implement any policy to support the use of these drugs. It was confirmed that these drugs would need to be commissioned by clinical commissioning groups.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
, "dateOfAnswer" : {"_value" : "2016-10-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-10-19T15:04:06.43Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-10-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Breast Cancer: Chemotherapy"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what discussions the Chemotherapy Clinical Reference Group has had on the use of bisphosphonates for the indication of preventing secondary breast cancer since July 2015.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/312", "label" : {"_value" : "Biography information for Dame Caroline Spelman"}
}
, "tablingMemberConstituency" : {"_value" : "Meriden"}
, "tablingMemberPrinted" : [{"_value" : "Dame Caroline Spelman"}
], "uin" : "48107"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&AnswerDate=2016-10-13&AnsweringBody.=Department+of+Health&version=1", "page" : 0, "startIndex" : 1, "totalResults" : 53, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|